Chitosan‐Fe (III) Complex as a Phosphate Chelator in Uraemic Rats: A Novel Treatment Option

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|122|1|120-125

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.122, Iss.1, 2018-01, pp. : 120-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mepolizumab—a novel option for the treatment of hypereosinophilic syndrome in childhood

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 29, Iss. 1, 2018-02 ,pp. : 28-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deferasirox: a novel, once-daily oral iron chelator

By Cappellini Maria Domenica  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 453-460

Future Medicine

Access to resources Recommend Favorite

Novel alginate-enclosed chitosan–calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy

By Kanwar Jagat R   Mahidhara Ganesh   Kanwar Rupinder K  

Nanomedicine, Vol. 7, Iss. 10, 2012-10 ,pp. : 1521-1550

Future Medicine

Access to resources Recommend Favorite

Gambling on treatment is not an option

By  

PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 20, Iss. 4, 2016-07 ,pp. : 29-34

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 1-9

Karger

Access to resources Recommend Favorite